$BMRN news

The latest BMRN stock news: headlines, filings, AI summaries and sentiment for $BMRN, updated around the clock.

• BIOMARIN PHARMACEUTICAL INC - 10-Q Filing SEC EDGAR · November 3, 2026, 21:34 UTC
• BioMarin Reports Record Q3 Revenue Growth and Projects $3.8B-$3.9B for 2026 Seeking Alpha · November 3, 2026, 05:59 UTC
• BioMarin Reports Q3 2026 Revenue Growth Driven by Amicus Therapeutics Acquisition Motley Fool · November 3, 2026, 04:23 UTC
• BIOMARIN PHARMACEUTICAL INC - 8-K Filing SEC EDGAR · November 2, 2026, 21:07 UTC
• BioMarin Pharmaceutical Scheduled to Report Q3 2026 Earnings Seeking Alpha · October 30, 2026, 17:19 UTC
• BioMarin Incurs $283M IPR&D Expense Impacting Q3 Earnings Seeking Alpha · October 6, 2026, 22:28 UTC
• BIOMARIN PHARMACEUTICAL INC - 8-K Filing SEC EDGAR · October 6, 2026, 20:24 UTC
• BioMarin Reports Positive Five-Year Data for Pompe Disease Combination Therapy CNBC · October 2, 2026, 16:18 UTC
• BIOMARIN PHARMACEUTICAL INC - 8-K Filing SEC EDGAR · September 30, 2026, 20:17 UTC
• BioMarin Advances Amicus Integration and VOXZOGO Revenue Growth Yahoo Finance · September 18, 2026, 17:02 UTC
• BIOMARIN PHARMACEUTICAL INC - 8-K Filing SEC EDGAR · September 15, 2026, 12:32 UTC
• BIOMARIN PHARMACEUTICAL INC - 8-K Filing SEC EDGAR · September 14, 2026, 13:27 UTC
• BioMarin Shares Rise After Reaching Patent Settlement with Ascendis Yahoo Finance · September 12, 2026, 17:02 UTC
• BioMarin Secures Royalties on Ascendis' Yuviwel in Patent Settlement Yahoo Finance · September 4, 2026, 16:26 UTC
• BioMarin to Present at Multiple Investor Conferences in September PR Newswire · September 2, 2026, 13:00 UTC
• BioMarin and Ascendis Settle Global Patent Disputes Over Yuviwel Yahoo Finance · August 31, 2026, 12:06 UTC
• BIOMARIN PHARMACEUTICAL INC - 8-K Filing SEC EDGAR · August 31, 2026, 10:57 UTC
• BioMarin Acquires Alesta Therapeutics for $275 Million to Expand Rare Disease Pipeline Yahoo Finance · August 18, 2026, 13:41 UTC
• BioMarin Acquires Alesta Therapeutics for $275M to Expand Rare Disease Pipeline Yahoo Finance · August 18, 2026, 11:50 UTC
• BioMarin Acquires Alesta Therapeutics for $275 Million Yahoo Finance · August 19, 2026, 17:24 UTC
• BioMarin Acquires Alesta Therapeutics for $275 Million in Deal with Potential Additional Payments CNBC · August 19, 2026, 15:17 UTC
• BioMarin and n-Lorem Foundation Collaborate on Treatment for Rare Genetic Disorder ReNU Syndrome Seeking Alpha · July 27, 2026, 14:28 UTC
• BIOMARIN PHARMACEUTICAL INC - 8-K Filing SEC EDGAR · July 13, 2026, 20:07 UTC
• FDA Accepts sNDA for Full Approval of BioMarin’s Voxzogo Seeking Alpha · July 13, 2026, 16:23 UTC
• BIOMARIN PHARMACEUTICAL INC - 8-K Filing SEC EDGAR · June 4, 2026, 20:25 UTC
• BioMarin's Phase 3 Trial of BMN 401 for ENPP1 Deficiency Meets One Co-Primary Endpoint Yahoo Finance · May 21, 2026, 13:29 UTC
• BioMarin Shares Rise on Positive Phase 3 Results for Voxzogo Seeking Alpha · May 20, 2026, 22:09 UTC
• BioMarin's Phase 3 Trial of BMN 401 Meets Only One Primary Endpoint Seeking Alpha · May 18, 2026, 15:18 UTC
• BioMarin Pharmaceutical Inc. Q1 2026 Earnings Call Summary Yahoo Finance · May 5, 2026, 00:22 UTC
• BioMarin Reports Record $3.22 Billion in Revenue for Q4 and Full Year 2025 Yahoo Finance · May 4, 2026, 17:30 UTC
• BioMarin Reports Q1 2026 Earnings with Revenue Growth and Guidance Update Motley Fool · May 4, 2026, 22:01 UTC
• BioMarin Reports Q4 2025 Earnings with Revenue Growth and Strategic Adjustments Motley Fool · May 4, 2026, 17:10 UTC